Show simple item record

dc.contributor.authorSismondo, Sergio
dc.contributor.editorDartigues, Laurent
dc.contributor.otherSaïdi, Samantha
dc.date.accessioned2023-12-06T09:44:51Z
dc.date.available2023-12-06T09:44:51Z
dc.date.issued2023
dc.identifierONIX_20231206_9791036291708_223
dc.identifier.issn2678-7806
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/131620
dc.languageFrench
dc.relation.ispartofseriesGouvernement en question(s)
dc.subject.classificationthema EDItEUR::J Society and Social Sciences::JP Politics and government::JPA Political science and theoryen_US
dc.subject.classificationthema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industriesen_US
dc.subject.otherBig Pharma
dc.subject.otherembedded and systemic corruption
dc.subject.otherleader d'opinion
dc.subject.otherghost-management
dc.subject.otherpublication planning
dc.titleLe management fantôme de la médecine
dc.title.alternativeLes mains invisibles de Big Pharma
dc.typebook
oapen.abstract.otherlanguageWhile most actors in the drug production chain should operate under the label of science, their knowledge is in fact drawn from streams of knowledge that have been fed, spread and maintained by the pharmaceutical industry, in an intimate dialogue between science and marketing. Operating in the shadows, many “invisible hands” working for Big Pharma elaborate this knowledge: publication planners commission ghostwritten medical journal articles; key opinion leaders and sales representatives are recruited and deployed to subtly change doctors’ behaviour; patient organisations, influenced by the industry, spread biased points of view on diseases and treatments. Ultimately, at the end of this ghostly production chain driven by this “assemblage marketing”, prescriptions written by doctors will “naturally” make way for the new drugs promoted by pharmaceutical companies. Addressing a wide audience, Sergio Sismondo’s aim, with this book of which we offer here a previously unpublished translation, is to lift the veil on the ghost management in the pharmaceutical industry, a management we should all be concerned about, given its major impact on public health.
oapen.identifier.doi10.4000/books.enseditions.46996
oapen.relation.isPublishedBy2ef10e66-6d3e-4b6d-9799-bf76360dd3e6
oapen.relation.isbn9791036291708
oapen.relation.isbn9791036206894
oapen.pages278
oapen.place.publicationLyon


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record